Cholbam (Cholic Acid) Patent Expiration, LOE Window & CMS Spending

Cholbam (Cholic Acid) by Mirum Pharmaceuticals: Off-Patent Uncontested (0 AB Generics), 0 AB generics, $39.1M 2024 CMS Part D & Medicaid spend, and 6 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorMirum Pharmaceuticals
FDA Application & PathwayN205750 (NDA)
Exclusivity / Cliff HorizonOff-Patent Uncontested (0 AB Generics)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$39.1M
2024 Medicare Part D Spend$5.9M
2024 Medicaid Spend$33.2M
Reported Wholesale Price Change (CA SB 17)6 WAC filings (max 19.1% 2-yr change)